Session Tracks

This track will explore the latest innovations in the development of antimicrobial drugs, focusing on novel compounds and therapeutic strategies. Researchers will present their findings on the efficacy and safety profiles of emerging agents.

This session will delve into the molecular and genetic mechanisms that underpin antibiotic resistance in various pathogens. Presentations will highlight recent discoveries and their implications for treatment strategies.

This track will examine effective public health interventions aimed at controlling infectious diseases. Discussions will include vaccination programs, surveillance systems, and community health initiatives.

This session will focus on the epidemiological trends of infectious diseases globally, analyzing factors that contribute to their spread. Researchers will present data on outbreaks and the impact of social determinants on disease transmission.

This track will address the ethical dilemmas faced in the use of antimicrobial therapies, including issues of access, stewardship, and informed consent. Experts will discuss frameworks for ethical decision-making in clinical practice.

This session will highlight the importance of antimicrobial stewardship programs in healthcare settings. Presentations will cover strategies for optimizing antibiotic use and reducing resistance rates.

This track will focus on the discovery and development of emerging antimicrobial agents, including peptides and other novel classes. Researchers will discuss their mechanisms of action and potential clinical applications.

This session will review the latest advancements in antitubercular, antifungal, and antiviral therapies. Experts will present findings on drug efficacy, resistance patterns, and treatment guidelines.

This track will explore the genetic basis of antibiotic resistance, focusing on the role of plasmids, transposons, and chromosomal mutations. Presentations will highlight the implications for public health and treatment options.

This session will discuss innovative strategies to combat antimicrobial resistance, including phage therapy, CRISPR technology, and alternative therapeutics. Researchers will share their insights on the future of resistance management.

This track will provide a platform for discussing global approaches to managing infectious diseases, including case studies from various countries. Presentations will emphasize collaborative efforts and lessons learned in combating epidemics.